Vulnerability to low-dose combination of irinotecan and niraparib in ATM-mutated colorectal cancer

Overview of attention for article published in Journal of Experimental & Clinical Cancer Research, January 2021

Altmetric Badge

Mentioned by

So far, Altmetric has seen 2 X posts from 1 X users, with an upper bound of 509 followers.

RT @JournalofExper1: New Study! 👇 𝐕𝐮𝐥𝐧𝐞𝐫𝐚𝐛𝐢𝐥𝐢𝐭𝐲 𝐭𝐨 𝐥𝐨𝐰-𝐝𝐨𝐬𝐞 𝐜𝐨𝐦𝐛𝐢𝐧𝐚𝐭𝐢𝐨𝐧 𝐨𝐟 #𝐢𝐫𝐢𝐧𝐨𝐭𝐞𝐜𝐚𝐧 𝐚𝐧𝐝 𝐧𝐢𝐫𝐚𝐩𝐚𝐫𝐢𝐛 𝐢𝐧 𝐀𝐓𝐌-𝐦𝐮𝐭𝐚𝐭𝐞𝐝 #𝐜𝐨𝐥𝐨𝐫𝐞𝐜𝐭𝐚𝐥𝐜𝐚𝐧𝐜𝐞𝐫 💻htt…

New Study! 👇 𝐕𝐮𝐥𝐧𝐞𝐫𝐚𝐛𝐢𝐥𝐢𝐭𝐲 𝐭𝐨 𝐥𝐨𝐰-𝐝𝐨𝐬𝐞 𝐜𝐨𝐦𝐛𝐢𝐧𝐚𝐭𝐢𝐨𝐧 𝐨𝐟 #𝐢𝐫𝐢𝐧𝐨𝐭𝐞𝐜𝐚𝐧 𝐚𝐧𝐝 𝐧𝐢𝐫𝐚𝐩𝐚𝐫𝐢𝐛 𝐢𝐧 𝐀𝐓𝐌-𝐦𝐮𝐭𝐚𝐭𝐞𝐝 #𝐜𝐨𝐥𝐨𝐫𝐞𝐜𝐭𝐚𝐥𝐜𝐚𝐧𝐜𝐞𝐫 💻https://t.co/2KzQCXULIY #DNAdamage #PARPinhibitors @IREISGufficiale https://t.co/IFQQi86d2S

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.